ROBOSENSE
19.5.2023 13:01:28 CEST | Business Wire | Press release
RoboSense, a world-leading provider of smart LiDAR sensor systems, today announced it is now connected to the NVIDIA Omniverse ecosystem, using the development platform based on Universal Scene Description (USD) to accelerate the development, testing, and validation of its sensor technology.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230519005153/en/
RoboSense Joins NVIDIA Omniverse Ecosystem RoboSense's second-generation smart solid-state LiDAR model is integrated into NVIDIA DRIVE Sim, built on Omniverse, enabling physically based, high-fidelity sensor simulation. (Graphic: Business Wire)
RoboSense's second-generation smart solid-state LiDAR model is integrated into NVIDIA DRIVE Sim, built on Omniverse, enabling physically based, high-fidelity sensor simulation. With this integration, autonomous vehicle developers can directly access state-of-the-art LiDAR for development and testing. (Video: RoboSense LiDAR Model in NVIDIA DRIVE Sim)
DRIVE Sim is a reference application built on NVIDIA Omniverse, the connecting fabric between software ecosystems. It combines NVIDIA’s core technologies to deliver digital twin environments for developing and testing autonomous driving systems. With DRIVE Sim, developers can perform diverse and repeatable testing scenarios at a large scale, accelerating development and reducing cost.
As part of the Omniverse ecosystem, RoboSense will use the simulation platform to test and validate its new LiDAR systems - as well as provide ADAS developers access to highly accurate simulation models.
RoboSense's M-Series LiDAR is the world's first second-generation smart solid-state LiDAR to achieve mass production for automotive applications. It is currently the LiDAR with the most designated partnerships worldwide and has been implemented in a variety of vehicle models including the GAC Aion LX Plus, GAC Aion Hyper GT, SAIC IM LS7, SAIC IM L7, Lotus Eletre, XPeng G9, XPeng P7i, Great Wall WEY Mocha DHT-PHEV, Great Wall Motor WEY DHT-PHEV, and Chery Exeed STERRA ES, STERRA ET.
The M-Series LiDAR features a revolutionary two-dimensional MEMS scanning architecture, with unique “GAZE” function that can dynamically switch scanning modes and change scanning patterns based on the scenario, improving vehicle perception in complex environments. Based on RoboSense's leading patented technology, the M-Series LiDAR delivers point-cloud with outstanding quality, helping to address corner cases in autonomous driving perception.
By joining the NVIDIA Omniverse ecosystem, RoboSense enables developers to create complex road environments with high physical accuracy using its LiDAR model on the DRIVE Sim platform. The M series LiDAR model offers the flexibility to simulate its performance in beam control, custom scan patterns, and resolutions, which can then be used to generate synthetic datasets for training and validation of autonomous driving solutions.
Mark Qiu, co-founder and executive president of RoboSense, said, “The global automotive industry is undergoing a massive transformation, with ADAS and LiDAR markets continuing to gain traction. Leveraging the NVIDIA Omniverse ecosystem, RoboSense LiDAR technology and industry experience can be applied in a wider field, providing strong support for the development and verification of autonomous vehicles. RoboSense will work with NVIDIA to fully leverage the advantages of LiDAR technology, continuously improve the perception capabilities of autonomous vehicles, and achieve more efficient, safer, and smarter autonomous driving applications. We are committed to promoting the development of the global automotive and autonomous driving industries.”
Zvi Greenstein, a general manager at NVIDIA, said, “NVIDIA Omniverse is an open platform that includes leading LiDAR models from manufacturers worldwide. RoboSense's outstanding technical strength and customer base help strengthen our ecosystem and will accelerate the development and validation of autonomous vehicles while bringing more flexibility to developers.”
About RoboSense
RoboSense (Suteng Innovation Technology Co., Ltd.) is a world-leading provider of Smart LiDAR Sensor Systems. With a complete portfolio of LiDAR sensors, AI perception and IC chipsets, RoboSense transforms conventional 3D LiDAR sensors with comprehensive data analysis and interpretation systems.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230519005153/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways Launches ‘Change the Tune in TRD’ in the U.S. to Advance HCP Understanding of Treatment-Resistant Depression at Psych Congress 202615.9.2026 12:30:00 CEST | Press release
New U.S. healthcare provider (HCP) disease education initiative, Change the Tunein TRD explores the neurobiology and care pathways to support greater recognition and understanding of treatment-resistant depression (TRD) TRD occurs when people with major depressive disorder (MDD) are failed by at least two different antidepressant treatment regimens of adequate dose, duration and adherence in the same episode Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, today announced the launch of Change the Tune in TRD, a new U.S. HCP disease education initiative, to deepen understanding and increase recognition of TRD. The campaign explores the neurobiology of this distinct form of depression and is designed to help navigate care pathways for patients and providers. Change the Tune in TRD was developed to provide evidence-based education to U.S. HCPs on the longer, more persistent episodes associated
NIQ Launches Digital Purchase GeoAudiences Across Europe15.9.2026 12:00:00 CEST | Press release
Building on NIQ's GeoPurchase capabilities, the new solution extends geographic purchase intelligence into digital-first categories across Europe NIQ (NYSE: NIQ), a leading consumer intelligence company, today announced the launch of Digital Purchase GeoAudiences across five European markets. The new solution extends NIQ’s geographic audience capabilities into digital-first categories including travel, automotive, technology, telecommunications and financial services. The launch expands NIQ’s GeoPurchase offering, which currently provides syndicated audiences across 13 international markets. Digital Purchase GeoAudiences address growing demand from advertisers for purchase-informed audience intelligence across a broader range of digital-first industries and shopping environments. By combining NIQ’s digital commerce intelligence with its GeoPurchase framework, the solution helps advertisers identify geographic areas showing stronger digital shopping activity. Marketers can use these sig
QurCan Therapeutics Enters Strategic Research and Collaboration Agreement with Lilly to Advance Nucleic Acid Therapies for Central and Peripheral Nervous System Diseases15.9.2026 12:00:00 CEST | Press release
Multi-program collaboration leveraging QurCan’s TERP™ polymer-lipid nanoparticle delivery platformLilly to make a strategic investment in QurCan QurCan Therapeutics (“QurCan”), a biotechnology company pioneering non-viral, polymer-lipid nanoparticle (PLNP) delivery of genetic medicines through its proprietary TERP™ (Target-Engineered Responsive Polymer) platform, today announced an exclusive research and collaboration agreement with Eli Lilly and Company (“Lilly”) for the treatment of diseases of the central nervous system (CNS) and peripheral nervous system (PNS). Lilly and QurCan will collaborate on multiple research programs focused on the development of PLNP-enabled genetic medicine therapeutics for CNS and PNS delivery. Through this collaboration, QurCan will be responsible for optimizing genetic medicine therapeutics using its TERP platform, and Lilly will be responsible for further research, clinical development, and commercialization of the selected programs. “This collaboratio
Axo Longevity Raises Oversubscribed $5M Seed Round to Build Europe’s Leading Preventive Health Membership15.9.2026 11:16:00 CEST | Press release
Live in six markets within twelve weeks of launch, with a 19,000-person waitlist Axo Longevity today announced the close of an oversubscribed $5M seed round to expand its preventive health membership across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260910642125/en/ Axo Longevity preventive health membership The round was backed by MS&AD Ventures, Izou Partners, LifeX Ventures, Everywhere Ventures, UNQ, 51 Ventures, Cistern Capital and NIAN Sports & Entertainment, alongside angel investors including Dr. Jorge Planas of Clinica Planas Barcelona and Daniel Kulle, former President of H&M and former CEO of Forever 21. Developed to help people understand what is happening inside their body before symptoms appear, Axo Longevity moved from build to live operations in just twelve weeks. The platform is expanding globally, now operating in the United Kingdom, Ireland, Spain, Germany, and the Netherlands, as well as in its
Chiesi Appoints David Khougazian as Group Chief Executive Officer to Lead the Next Phase of Innovation-Driven Growth15.9.2026 11:00:00 CEST | Press release
Highlights: David Khougazian appointed Group Chief Executive Officer to lead Chiesi's next phase of innovation-driven growth, effective 15 October 2026. Bringing over 25 years of international healthcare leadership experience and a strong track record in innovation and transformation, David joins Chiesi from Flagship Pioneering. Chiesi Group (Chiesi) today announced the appointment of David Khougazian as Group Chief Executive Officer (CEO), effective 15 October 2026. David joins Chiesi following a distinguished international career spanning more than 25 years across the global healthcare and life sciences sectors. Most recently, he served as Executive Partner, Growth, and Head of Global Engagement at Flagship Pioneering, where he supported the growth and development of science-driven healthcare companies and worked closely with leadership teams on long-term value creation, partnerships, financing and organizational development. Following a thorough selection process led by the Board of
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom